
#globalhealthfighter looking for new ways to improve #access to care for #NCDs in #LMICs. Tweets are in my personal capacity.
Joined April 2009
- Tweets112
- Following299
- Followers135
- Likes376
Happy #WorldDiabetesDay! There is so much that can be done to improve the experience of people living with diabetes and that of their healthcare providers! #access2meds #health4all
On the occasion of #WorldDiabetesDay, we spoke with 2⃣ patients and 2⃣ healthcare professionals & discussed the desperate need for more affordable and higher-quality medicines for people in low- and middle-income countries.
Sarne Matsumura 🇿🇦, Mercy Annapurna 🇮🇳, Sister Buyelwa Majikela-Dlangamandla 🇿🇦, and Dr. Raja Sakkarapani 🇮🇳 shared their thoughts on access to #diabetes care.
👉🏾bit.ly/469iL9b
Giulia Segafredo retweeted
All lives matter regardless of where one lives. Engagements will continue to ensure equitable access @MedsPatentPool @UWOCASOfficial @GiuliaESSE @UgandaCancerIns @UgCancerSociety @UCCF_Official @UCCF_Official @PCAUganda
Thanks @SalomeMeyer1 @dejoh1 @GNakigudde @breastlessAfrik @damilnermd for the inspiring session on how to improve #access to innovative #medicines in Africa!
improving access to cancer medicines can contribute to break the vicious cycle, and improve cancer diagnosis and, more broadly, cancer care @AORTIC_AFRICA #dakar2023 @MedsPatentPool @eburrone
Thanks @SalomeMeyer1 @dejoh1 @GNakigudde @breastlessAfrik @damilnermd for the inspiring session on how to improve #access to innovative #medicines in Africa!
#AORTIC2023 🇸🇳| 🎙️MPP's @GiuliaESSE explained how the MPP model can support access to essential and innovative #oncology medicines in #LMICs.
👏🏾The session was organised by #cancer advocates @SalomeMeyer1 @breastlessAfrik @GNakigudde @dejoh1.
🙏🏾Thanks to @damilnermd for chairing the session & to @VanderpuyeVerna for her insightful presentation.
Thrilled to see what such an amazing and inspiring leader will be doing for cancer patients in #africa! @m_mutebi we will all be at your side to improve cancer care and #access to #essentialmedicines in the continent!
Replying to @AORTIC_AFRICA
@AORTIC_AFRICA @CANCERKESHO @uicc @poher That feeling when you realize that you are about to assemble the brightest minds across the cancer continuum to discuss strategies to shift narratives for Ca patients in 🌍 ! Join the dialogue #AORTIC2023 #accessforall #workforce
Happy Cancer Survivor Day! Thanks @GNakigudde for sharing your amazing story - together, we can leave no one behind. @MedsPatentPool #meds4all #ATOM #ASCO2023 @SalomeMeyer1 @breastlessAfrik @dejoh1
CEO of @UWOCASOfficial, @Gnakigudde of #Uganda🇺🇬 has been a breast #cancer survivor for 21 years.
On #NationalCancerSurvivorsDay she shares her advocacy experience fighting for access to #cancer treatment and care in #LMICs.
#NCSD2023 @UgandacancerIns youtu.be/d9xrs0wx5pA
Is this health equity? 70% of deaths for cancer hare occurring in LMICs vs 5% of the resources spent on cancer are spent in LMICs @m_mutebi @GlopesMd @damilnermd @ATOM_Coalition #ASCO2023 #meds4all
The meeting of the 24th WHO Expert Meeting on the Selection and Use of Essential Medicines is starting next Monday. The open session is a great opportunity to understand the activities around the EML and access to essential meds. Find the link to register 👇🏽
Essential Medicines - EML Open Session
Listen to an update on current and future activities related to prioritarization and access to essential medicines
Register here in case you are interested who.zoom.us/webinar/register…
This is the first day we’ve been working with our new Community Advisory Panel. It is inspiring, super motivating, and I am excited about all the things we can do together! @breastlessAfrik @SalomeMeyer1 @dejoh @GNakigudde @AlyBancroft @MridulaKapil @MedsPatentPool
🗣️ We #JustLaunched our Community Advisory Panel (CAP)‼️
⏳The CAP is a new mechanism that serves a key advisory role in providing MPP and our Expert Advisory Group with critical insights and guidance from its members’ expertise and lived experiences.
👉🏽bit.ly/3THzTys
#essentialmeds Applications for consideration by the WHO Expert Committee for the Selection and Use of Essential Medicines are now public. One of the key moments to make access to meds more real #MedsForAll #HealthForAll
"The meeting of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines will be held at WHO Headquarters, Geneva, from 24 to 28 April 2023...Applications for consideration by the Expert Committee consideration are published below."
who.int/groups/expert-commit…
Aiutatemi a capire. Le donne che hanno avuto figli, possono andare in pensione prima di quelle che non li hanno avuti. Ma a 58 anni, i figli sono grandi. non avrebbe senso fornire aiuti alle madri quando i bimbi sono piccoli e non discriminare le donne davanti alla pensione?
Biotherapeutics represent an enormous clinical opportunity, especially for NCDs. Low access to these medicines in LMICs is simply unacceptable. We tried to understand how we can fill this gap, here some of our considerations. @MedsPatentPool @Seb_Morin_GVA @eburrone
📃#Publication|@LancetGH has just published a paper by MPP co-authors on expanding access to #biotherapeutics in #LMICs through #PublicHealth non exclusive voluntary #IntellectualProperty licensing.
Access the document > bit.ly/3AOmJr9
Hongera sana @MaryNyangasi @m_mutebi for such an achievement!
Official launch of the Comprehensive Breast Care Centre at Kenyatta University Teaching, Referral and Research Hospital (KUTRRH).
@kutrrh @m_mutebi @MaryNyangasi @helena_musau @CancerProgram
Giulia Segafredo retweeted
#BREAKING|🤝🏽@MedsPatentPool signs a licence agreement with @Novartis to increase access to #nilotinib for the treatment of chronic myeloid #leukaemia.
Access our #PressRelease👉🏽 bit.ly/3ERBagI
@ATOM_Coalition
#HealthForAll #Access2Meds #PublicHealth #cancer #WCC2022
this actually happened! It was inspiring meeting such a pool of motivated #access advocates! thanks for sharing your enthusiasm! @MedsPatentPool
#HappeningNow | Our Meet the Expert session at the #WorldCancerCongress
🎙@GiuliaESSE, our #NCDs Access Manager, shares her thoughts on what is voluntary licensing and why does it matter to access #cancer #medicines.
#WCC2022
drugs need to become #available, this is the first step to drive the development of #healthsystems. We are at a turning point and this community can make the difference! Thanks to our panel @ymartei @MaryNyangasi @PatGarciaGonzal @pahowho @eburrone @MedsPatentPool
Replying to @MedsPatentPool
#WCC2022|Final words from MPP's @eburrone > we're at a turning point. We keep on hearing that #cancer is complex. Let's try new ways of providing #access2meds that have worked in other disease areas 👉🏽voluntary licensing is one of them.
#worldcancercongress is about to kick off. Join our panel on #access to #essentialmedicines for #cancer on Tuesday 18th at 3,30pm. You’ll hear some best practices on how we can make #access in LMICs more possible! @MedsPatentPool @ymartei @eburrone @PatGarciaGonzal @MaryNyangasi
Don't miss us at the #WorldCancerCongress! 🌟
#MarkYourCalendar
🗓️Tuesday 18 October 2022
⏰15:30-16:30 CET
Join us as we discuss “Increasing Access to Quality Assured and Affordable Essential Medicines for #Cancer Care in #LMICs – How Can We Make This Happen?”
#WCC2022
Happy birthday #medspal! Thanks for teaching us so much about medicines’ patents and how they can represent a barrier to #access! @MedsPatentPool
Wow! Already 6 years! It all started with an oversized excel sheet and developed into a huge database covering 140 essential meds. I particularly wish to thank @PascaleBoulet who conceptualized and managed it at the start, and Amina Maillard who has led it for the past 4 years.
And guess how is the #access to antivenoms in lower-middle income countries? No #availability and No #affordability @MSF_access
This quoted post is unavailable.
Giulia Segafredo retweeted
📣 Hey #ESMO2022 👋 We have positions open at @MedsPatentPool ! Join us to contribute to increasing access to #Health solutions for #LMICs #ScientificManager #ExpertAdvisor #CommunityAdvisor #cancer medicinespatentpool.org/who-…
































